1. Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta‐analysis. Issue 10 (28th May 2014) Authors: Liakos, A.; Karagiannis, T.; Athanasiadou, E.; Sarigianni, M.; Mainou, M.; Papatheodorou, K.; Bekiari, E.; Tsapas, A. Journal: Diabetes, obesity & metabolism Issue: Volume 16:Issue 10(2014:Oct.) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials. Issue 11 (23rd September 2015) Authors: Karagiannis, T.; Liakos, A.; Bekiari, E.; Athanasiadou, E.; Paschos, P.; Vasilakou, D.; Mainou, M.; Rika, M.; Boura, P.; Matthews, D. R.; Tsapas, A. Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 11(2015:Nov.) Page Start: 1065 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prevalence of increased arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus. (September 2016) Authors: Tziomalos, K.; Gkougkourelas, I.; Sarantopoulos, A.; Bekiari, E.; Makri, E.; Raptis, N.; Tselios, K.; Pantoura, M.; Hatzitolios, A.; Boura, P. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prevalence of increased arterial stiffness and peripheral arterial disease in patients with systemic sclerosis. (September 2016) Authors: Tziomalos, K.; Gkougkourelas, I.; Sarantopoulos, A.; Bekiari, E.; Raptis, N.; Makri, E.; Tselios, K.; Pantoura, M.; Hatzitolios, A.; Boura, P. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗